FADS2 and neuroblastoma: Expression of FAS, ELOVL6, SCD, FADS2, and FADS1 was associated with elevated risk of death in NB patients from both studies, whereas ELOVL5 and ELOLV2 expression was associated with reduced risk (Figure 4a).